GlassScriptPhysician profile
Gene Schwartz
NPI 1457618456
$5,871.98
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,125 · 2020: $2,158 · 2021: $492 · 2022: $97.34.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,654.13 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $688.68 | 2019-2020 | |
| Vyne Pharmaceuticals INC. | $457.46 | 2020-2021 | |
| Genzyme Corporation | $446.79 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $433.79 | 2019-2021 | |
| Celgene Corporation | $364.31 | 2019 | |
| Lilly USA, LLC | $328.32 | 2019-2020 | |
| Amgen INC. | $299.51 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $182.29 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $155.87 | 2019 | |
| Paratek Pharmaceuticals, INC. | $143.82 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $124.26 | 2019 | |
| Almirall LLC | $123.10 | 2019 | |
| Galderma Laboratories, L.P. | $119.69 | 2020 | |
| Genentech USA, INC. | $99.00 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epi Health, LLC | $97.34 | 2022 | |
| Pfizer INC. | $97.10 | 2019 | |
| Janssen Biotech, INC. | $35.95 | 2019-2020 | |
| Kyowa Kirin, INC. | $20.57 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gene Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.